Case Presentation. Case Presentation. Case Presentation. Truths about Headaches (2017) Most headaches were muscle-tension headaches

Similar documents
ADVANCES IN MIGRAINE MANAGEMENT

Index. Prim Care Clin Office Pract 31 (2004) Note: Page numbers of article titles are in boldface type.

OH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES

MIGRAINE UPDATE. Objectives & Disclosures. Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment.

A case of a patient with chronic headache. Focus on Migraine. None related to the presentation Grants to conduct clinical trials from: Speaker bureau:

Headache A Practical Approach

How do we treat migraine? New SIGN Guidelines

Strategies in Migraine Care

Update on Diagnosis and Management of Migraines

Goals. Primary Headache Syndromes. One-Year Prevalence of Common Headache Disorders

Clinical Learning Days November 10, 2017

10/31/2017 PRIMARY CARE AND HEADACHE DISCLOSURES WHERE DO THOSE WITH HEADACHE SEEK MEDICAL CARE? Primary Care 67%

Headache. Headache Case. Migraine Headache. Eric Kraus, MD. Types» Without aura (common)» With aura (classic)

Faculty Disclosure. Karen L. Bremer, MD. Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest.

Headache Questionnaire

Migraine, Tension, and Cluster Headache: Primary Care for Primary Headaches. Jonathon M. Firnhaber, MD, FAAFP

Anti-Migraine Agents

Clinical Policy: Triptans Reference Number: CP.CPA.217 Effective Date: Last Review Date: Line of Business: Commercial

Short Clinical Guidelines: Headache, Key Points for Diagnosis and Treatment

Disclosures. Triptans for Kids 5/16/13

Triptan Quantity Limit

Triptans Quantity Limit Program Summary

Clinical Policy: Triptans Reference Number: CP.HNMC.217 Effective Date: Last Review Date: Line of Business: Medicaid Medi-Cal

Page: 1 of 6. Aimovig (erenumab-aooe) injection, Ajovy (fremanezumab-vfrm) injection, Emgality (galcanezumab-gnim)

Treatment of Primary Headache Syndromes

Headache. Section 1. Migraine headache. Clinical presentation

Prevention and Treatment of Migraines CAITLIN BARNES, PHARM.D. CANDIDATE AMBULATORY CARE JOE CAMMILLERI, PHARM.D. NATOHYA MALLORY, PHARM.D.

Understanding Migraines and Treatment Options. Simplified Diagnosis of Migraine. Migraine Prevalence American Migraine Study II

HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in

ABORTIVE AGENTS. Average cost per 30 days. Form Limits SEROTONIN AGONISTS $ $ Reserved for treatment failure to either Sumatriptan PA; QL

Abortive Agents. Available Strengths. Formulary Limits. Tablet: 5mg, 10mg ODT: 5mg, 10 mg 25mg, 50mg, 100mg. 5mg/act, 20mg/act

Clinical Policy: Triptans Reference Number: CP.CPA.217 Effective Date: Last Review Date: Line of Business: Commercial

Adult & Pediatric Patients. Stanford Health Care, Division Pain Medicine

MIGRAINE A MYSTERY HEADACHE

HEADACHE: Benign or Severe Dr Gobinda Chandra Roy

I have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation.

MEASURE #3: PREVENTIVE MIGRAINE MEDICATION PRESCRIBED Headache

UTILIZATION MANAGEMENT CRITERIA

2008 Migraine Update Migraine Update Migraine Update. Epidemiology. Yousef Mohammad MD., MSc. Epidemiology

10/17/2017 CHRONIC MIGRAINES BOTOX: TO INJECT OR NOT INJECT? IN CHRONIC MIGRAINE PROPHYLAXIS OBJECTIVES PATIENT CASE EPIDEMIOLOGY EPIDEMIOLOGY

Migraine Management. Jane Melling Headache nurse Mater Misericordiae Hospital

Jessica Ailani MD FAHS Director, Georgetown Headache Center Associate Professor Neurology Medstar Georgetown University Hospital

Can I send this headache patient home? Dr Nicola Giffin Consultant Neurologist Bath, Nov 2017

SUMAVEL DOSEPRO (sumatriptan succinate) solution for injection

Chronic Daily Headaches

Headaches: An Approach to Evaluation & Management

Medication For Migraine Chart: Table 1: Acute Treatment when the attack begins

Headache and Facial Pain. Mohammed ALEssa MBBS, FRCSC Assistant Professor Consultant Otolaryngology,Head & Neck Surgical Oncology

Chronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary

Faculty Disclosures. Learning Objectives. Acute Treatment Strategies

Maxalt. Maxalt / Maxalt-MLT (rizatriptan) Description. Section: Prescription Drugs Effective Date: April 1, 2016

Management of headache

Understanding Migraines

Regulatory Status FDA approved indication: Migranal Nasal Spray is indicated for the acute treatment of migraine headaches with or without aura (1).

Differential Diagnosis of Headaches

Treatments for migraine

Acute Migraine Treatment in Adults

ONZETRA XSAIL (sumatriptan) nasal powder

Approach to a Patient with Headache

COLUMBIA UNIVERSITY HEADACHE CENTER: NEW PATIENT QUESTIONNAIRE

Headache evaluation and management after concussion. Assistant Professor

Migranal Nasal Spray. Migranal Nasal Spray (dihydroergotamine) Description

Migraine Migraine Age Specific Prevalence in the United States. Headache International Headache Society Classification

Come prepared: What you can expect:

Çiçek Wöber-Bingöl HEADACHE UNIT FOR CHILDREN AND ADOLESCENCE

Migraine: Past, Present and Future Edward O Sullivan September 12 th 2015 Dublin 12/09/2015

TABLE 1. Current Diagnostic Criteria for Migraine Without Aura 2 A. At least 5 attacks fulfilling criteria B-D B. Headache attacks lasting 4-72 hours

Long-Term Care Updates

PREVALENCE BY HEADACHE TYPE

2) Headache - Dr. Hawar

Stanley J. Krolczyk DO, RPH Assistant Professor of Neurology University of South Florida College of Medicine Tampa, Florida

Migraine Controversies in Women s Health. Professor Peter J. Goadsby 5 December Department of Neurology

Reviews/Evaluations. Medication-Overuse Headache

9/2/2010. Pediatric Headache: Learning Objectives: Learning Objectives: Lynn Clark RN, PNP-BC Alicia Haag RN, FNP-C. Objective 7:

ปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา

Imitrex for ocular migraines

Headache Master School Japan-Osaka 2016 (HMSJ-Osaka2016) October 23, II. Management of Refractory Headaches

Outpatient Headache Care Guideline

Headache: A case-based approach

Emerging Challenges in Primary Care: Brainstorm: A Symposium on Migraine Treatment and Management

Migraine Clinical Guideline

Primary Care Adult Headache Management Pathway (formerly North West Headache Management Guideline for Adults) Version 1.0

1. On how many days in the last 3 months did you miss work or school because of your headaches?

Pharmacy Medical Necessity Guidelines: Migraine Medications

Dubai Standards of Care (Migraine)

SIGN on the pharmacological management of migraine

The Pediatric Headache Handbook

Drug Name (select from list of drugs shown / provide drug information) Patient Information. Prescribing Physician

MEASURE #1: MEDICATION PRESCRIBED FOR ACUTE MIGRAINE ATTACK Headache

IMITREX UTILIZATION MANAGEMENT CRITERIA

Outline. Etiology. General information. Definition 4/13/2012

Current Migraine Treatment Therapy. Daniel Kassicieh, DO, FAAN

Overuse of barbiturate and opioid containing medications for primary headache disorders Description

ARxCH. Annual Review of Changes in Healthcare. Calcitonin Gene-Related Peptide Receptors and the Prevention of Migraines. Abstract

Farjam Farzam, M.D. Pediatric Neurology

Headache Mary D. Hughes, MD Neuroscience Associates

What You Should Know About Your HEADACHE. Learn more about headache types, triggers, and treatments, when to get help, and how to help yourself

Migraine in Children. Germano Falcao, MD Pediatric Neurology 03/07/2014

*** Drug Safety Alert ***

Paediatric headaches. Dr Jaycen Cruickshank Director of Clinical Training Ballarat Health Services. Brevity, levity, repetition

Transcription:

Agenda Case presentation Migraine Morphology Primary and Premonitory Phase Secondary Headache Aura Headache Primer on Pain Medication Overuse Headache Case Presentation RT is a 25 year old woman with daily headache Global HA for past 6 months Formerly occasional HA beginning with wavy visual distortion for 20 minutes Then nausea & unilateral HA throbbing for 4+ hours Case Presentation RT is a 25 year old woman with daily headache Typically resolved after sleeping Some benefit from ibuprofen 600 mg HA daily 1 week before menses Frequency increasing until now HA every day Case Presentation RT is a 25 year old woman with daily headache Addressed triggers including sleep changes, OCP; stressful events; eat breakfast; decrease caffeine Amitriptyline 10 mg at bedtime No other analgesic for 2 weeks Breakthrough HA: 100% respond to zolmitriptan Truths about Headaches (1980) Most headaches were muscle-tension headaches Migraines (and cluster) were vascular headaches Migraine aura was due to vasospasm Drugs were Anacin, Fiorinal, Cafergot, or Midrin Truths about Headaches (2017) Most headaches were muscle-tension headaches Migraines (and cluster) were vascular headaches Migraine aura was due to vasospasm Drugs were Anacin, Fiorinal, Cafergot, or Midrin

International Headache Society Classification of Migraine Necessary At least 2 At least 1 Episodic 4 36 hours Unilateral Photophobia Throbbing Phonophobia Aggravated by movement Nausea or vomiting Headache Nomenclature Primary Secondary Paroxysmal Chronic Severe Synonyms Common migraine Migraine without aura Migraine with aura Muscle tension Tension type Primary Paroxysmal Headache Not Migraine Headaches Cluster Paroxysmal hemicrania Orgasmic Primary Chronic Headache Medication Overuse Headache Transformed migraine Chronic migraine Chronic daily headache Secondary Headache Secondary Headache Meningeal irritation Temporal arteritis Post concussion Cocaine Pituitary apoplexy Cervical artery dissection Facial pain (sinusitis, etc.) Brain tumor Subdural hematoma Intracranial hypertension Subarachnoid hemorrhage Normal pressure hydrocephalus Call Fleming Syndrome (diffuse cerebral vasculopathy) Many medical illnesses

Pain Pathway 1 1 Nociceptor stimulation Primer on Pain 2 Spinal interneuron (Substance P) 3 Midbrain signal modulation 4 Thalamic synapse 5 Parietal cortex Nociceptor Threshold Thought Experiment Nociceptor Threshold Migraine as a Dysfunctional Neurolimbic Pain Network Maizels M, Aurora S, Heinricher M. Headache (2012) 52;10:1553-65

Migraine Morphology Premonitory phase Aura Headache Postdromic phase Premonitory Phase Irritable Fatigued Mood changes Difficulty concentrating Nausea Cravings Premonitory Phase Irritable Fatigued Mood changes Difficulty concentrating Nausea Cravings Triggers Sleep (too much or too little) Fasting Caffeine (too much or withdrawal) Alcohol Estrogen Aura Provides a Clue Visual Aura 1. Lashley draws an aura 2. Leão describes spreading electrochemical depression 3. Lauritzen and Olesen measure regional cerebral blow flow (rcbf) of cortex Olesen J in The Headaches Olesen J, Tfelt-Hansen P, Welch KMA editors (1993) Raven Press, New York;264

Spreading Depression of Leão rcbf During Aura Teive H et al. Neurology 2005;65:1455-1459 Lauritzen M, Olesen J. Brain.1984; 107: 447-461 Independent Characteristics of Aura Functional Neuroimaging During Aura Observer Lashley Aura (1943) Leão Cortical Spreading Depression (1943) Olesen rcbf (1983) Velocity 2 3 mm/min 3 mm/min 3 mm/min Lakhan SE, Avramut M, Tepper SJ. (2013) Headache 53;1:146-66. Sensory Associations Colic Motion sickness Ice pick-like head pain Acute treatment Treatment Preventive treatment Freezer brain

Acute treatment (1) NSAID Acetaminophen Triptans (Serotonin receptor antagonists) Choose route of administration Choose formulary compliance DHE Metoclopramide Triptans Drug PO SC IN Transbuccal Sumatriptan Imitrex Sumavel Almotriptan Axert Eletriptan Relpax Frovatriptan Frova Naratriptan Amerge Rizatriptan Maxalt Zolmitriptan Zomig Acute treatment (2) Directions For Triptans and DHE Take one dose at onset Repeat once if HA persists at 1-2 hours If HA remits, but then returns, repeat same dose at 8-10 hours Do not treat more than 3 HA events in a week Barbiturate and Opiates Increase Transformation Lipton RB. Neurology (2009). 72;5: Supplement 1S3-S7 Cost of Transformation from Episodic to Chronic Preventive Treatment (1) Good Evidence Low dose tricyclic Topiramate and Divalproex Nadolol, metoprolol, timolol, propranolol Lipton RB. Neurology (2009) 72;5: Supplement 1S3-S7 Pringsheim T, Davenport WJ, Becker WJ. CMAJ. (2010) 182;7: E269-E276

Preventive Treatment (2) Inconclusive Evidence Gabapentin Venlafaxine Preventive Treatment (3) Good Evidence Against Pregabalin, Duloxetine Lamotrigine SSRI - ALL Pringsheim T, Davenport WJ, Becker WJ. CMAJ. (2010) 182;7: E269-E276 Pringsheim T, Davenport WJ, Becker WJ. CMAJ. (2010) 182;7: E269-E276 Special Considerations Hypertension CVD Nadolol, Propranolol, ACEi (?) Initial insomnia Amitriptyline Mood disorder Amitriptyline, Venlafaxine Self Diagnosis of Headaches Epilepsy Obese Intolerance of side effects Pregnant or Trying to Conceive Oral Contraceptives Topiramate, Divalproex, Gabapentin Topiramate Riboflavin, CoQ, Butterbur Contraindicated Divalproex Contraindicated Topiramate Tepper SJ, et al. Headache (2004) 44:856-64 Self Diagnosis of Headaches When patients see a doctor for headache, if they say I think I have a migraine. They are almost always right. I think I have a headache that is not a migraine. They are almost always wrong. Tepper SJ, et al. Headache (2004) 44:856-64